THE IMMUNOLOGICAL ROLE OF ANTI-H. PYLORI ANTIBODIES LEVEL, INF-Γ, AND TNF-Α IN A NUMBER OF PATIENTS WITH A TUMOR IN THE DIGESTIVE SYSTEM IN BABYLON GOVERNORATE

General Background: Helicobacter pylori is a well-known bacterium responsible for chronic infections, significantly contributing to gastric and mucosa-associated lymphoid tissue cancers, as well as peptic ulcer disease. Specific Background: The link between H. pylori infection and gastrointestinal (GIT) tumors remains under-explored, particularly concerning immunological parameters. Knowledge Gap: The role of immune markers, such as anti-H. pylori IgG antibodies, TNF-α, and IFN-γ, in distinguishing between malignant and benign GIT tumors is unclear. Aims: This study aimed to assess the relationship between H. pylori infection and immunological factors in patients with malignant and benign GIT tumors, as well as controls, using serum levels of Anti-H. pylori IgG, TNF-α, and IFN-γ. Results: The study included 100 serum samples from patients with malignant (n=40) and benign (n=35) GIT tumors, irritable bowel disease (IBD) controls (n=15), and healthy controls (n=10). The results revealed significantly elevated levels of anti-H. pylori IgG in patients with malignant tumors compared to those with benign tumors, IBD controls, and healthy controls. Male patients had higher anti-H. pylori IgG levels than females. Elevated levels of TNF-α and IFN-γ were also observed in patients with malignant tumors, correlating with higher anti-H. pylori IgG levels. Novelty: This study highlights the association between elevated H. pylori IgG antibodies and increased TNF-α and IFN-γ levels in malignant GIT tumors, particularly in males, suggesting H. pylori's role in cancer progression. Implications: The findings suggest that early detection of elevated anti-H. pylori IgG and inflammatory cytokines could improve the diagnosis and management of GIT malignancies, especially in male populations. Further research on a larger cohort is recommended to explore the mechanisms driving this relationship.

Authors

Publication Details

Journal
International Journal Multidisciplinary (IJMI)
Published
2024-09-21
DOI
https://doi.org/10.61796/ijmi.v1i3.184
Primary Topic
Helicobacter pylori-related gastroenterology studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

THE IMMUNOLOGICAL ROLE OF ANTI-H. PYLORI ANTIBODIES LEVEL, INF-Γ, AND TNF-Α IN A NUMBER OF PATIENTS WITH A TUMOR IN THE DIGESTIVE SYSTEM IN BABYLON GOVERNORATE

Raheem Tuama Obayes Al- Mammori, Hasanain Khaleel Shareef, Salim Shamkhi Jaafar, Ehab Y. Jabber et al.
International Journal Multidisciplinary (IJMI)
Helicobacter pylori-related gastroenterology studies
article

THE IMMUNOLOGICAL ROLE OF ANTI-H. PYLORI ANTIBODIES LEVEL, INF-Γ, AND TNF-Α IN A NUMBER OF PATIENTS WITH A TUMOR IN THE DIGESTIVE SYSTEM IN BABYLON GOVERNORATE

Raheem Tuama Obayes Al- Mammori, Hasanain Khaleel Shareef, Salim Shamkhi Jaafar, Ehab Y. Jabber, Amer Abdul Husain Alwish
article en

Abstract

General Background: Helicobacter pylori is a well-known bacterium responsible for chronic infections, significantly contributing to gastric and mucosa-associated lymphoid tissue cancers, as well as peptic ulcer disease. Specific Background: The link between H. pylori infection and gastrointestinal (GIT) tumors remains under-explored, particularly concerning immunological parameters. Knowledge Gap: The role of immune markers, such as anti-H. pylori IgG antibodies, TNF-α, and IFN-γ, in distinguishing between malignant and benign GIT tumors is unclear. Aims: This study aimed to assess the relationship between H. pylori infection and immunological factors in patients with malignant and benign GIT tumors, as well as controls, using serum levels of Anti-H. pylori IgG, TNF-α, and IFN-γ. Results: The study included 100 serum samples from patients with malignant (n=40) and benign (n=35) GIT tumors, irritable bowel disease (IBD) controls (n=15), and healthy controls (n=10). The results revealed significantly elevated levels of anti-H. pylori IgG in patients with malignant tumors compared to those with benign tumors, IBD controls, and healthy controls. Male patients had higher anti-H. pylori IgG levels than females. Elevated levels of TNF-α and IFN-γ were also observed in patients with malignant tumors, correlating with higher anti-H. pylori IgG levels. Novelty: This study highlights the association between elevated H. pylori IgG antibodies and increased TNF-α and IFN-γ levels in malignant GIT tumors, particularly in males, suggesting H. pylori's role in cancer progression. Implications: The findings suggest that early detection of elevated anti-H. pylori IgG and inflammatory cytokines could improve the diagnosis and management of GIT malignancies, especially in male populations. Further research on a larger cohort is recommended to explore the mechanisms driving this relationship.

International Journal Multidisciplinary (IJMI)Vol. 1(3)
Good health and well-being
Openalex Percentile: Top 59%
Helicobacter pylori-related gastroenterology studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.